The effect of lesions of ascending noradrenaline pathways on sleep and waking in the rat.
D000818:Animals; D001921:Brain / Q000502:physiology*; D001931:Brain Mapping; D002531:Cerebellum / Q000378:metabolism; D002540:Cerebral Cortex / Q000502:physiology; D004027:Diencephalon / Q000378:metabolism; D004569:Electroencephalography; D004576:Electromyography; D006624:Hippocampus / Q000502:physiology; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000378:metabolism; D008297:Male; D008636:Mesencephalon / Q000033:anatomy & histology / Q000502:physiology*; D008854:Microscopy, Electron; D009132:Muscles / Q000502:physiology; D009475:Neurons, Afferent / Q000502:physiology; D018377:Neurotransmitter Agents; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012890:Sleep; D012894:Sleep Stages; D009435:Synaptic Transmission; D013687:Telencephalon / Q000378:metabolism; D014316:Tritium; D014851:Wakefulness
D006892:Hydroxydopamines; D018377:Neurotransmitter Agents; D014316:Tritium; D009638:Norepinephrine